tirzepatide vs semaglutide weight loss study Tirzepatide: Which GLP-1 Wins for Loss? Avono Health | GLP-1 Explained:
Description
Steady state timeline by dose level
Some providers and researchers have explored extended titration as a tolerability strategy, but this hasnt been formalized into clinical guidelines
The 10 mg vial gives about 66 doses at 150 mcg
In contrast, Wegovy led to approximately 14.9% mean body weight loss at week 68 in patients who followed a protocol in Novos STEP trial
